Heart Disease Trial, Recruiting (NCT04295252)

Heart Disease Trial, Recruiting NCT04295252 Sponsor: Niguarda Hospital Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT04295252 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are admitted to hospital with a serious heart condition called cardiogenic shock (where the heart cannot pump enough blood to meet the body's needs) at one of the participating hospitals, between January 2020 and December 2030.
People whose blood pressure is dangerously low (systolic blood pressure below 90 mmHg or average arterial pressure below 60 mmHg), even after receiving fluids, OR who need medications or a mechanical device to keep their blood pressure at a safe level.
People who also show at least one sign that their body is not getting enough blood flow — such as low oxygen levels in the blood returning to the heart, high levels of a waste product called lactate in the blood (above 2 mmol/L), or producing very little urine (less than 0.5 ml per kilogram of body weight per hour for at least 6 hours).

Who may not be able to join:

People who do not meet the specific definition of cardiogenic shock as described above (confirm with trial site).
People who are not admitted to one of the participating hospital centres during the study period.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +39026444

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04295252

Sponsor: Niguarda Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: +39026444

More information: https://clinicaltrials.gov/study/NCT04295252

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are admitted to hospital with a serious heart condition called cardiogenic shock (where the heart cannot pump enough blood to meet the body's needs) at one of the participating hospitals, between January 2020 and December 2030.
People whose blood pressure is dangerously low (systolic blood pressure below 90 mmHg or average arterial pressure below 60 mmHg), even after receiving fluids, OR who need medications or a mechanical device to keep their blood pressure at a safe level.
People who also show at least one sign that their body is not getting enough blood flow — such as low oxygen levels in the blood returning to the heart, high levels of a waste product called lactate in the blood (above 2 mmol/L), or producing very little urine (less than 0.5 ml per kilogram of body weight per hour for at least 6 hours).

Who may not be able to join:

People who do not meet the specific definition of cardiogenic shock as described above (confirm with trial site).
People who are not admitted to one of the participating hospital centres during the study period.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Niguarda Hospital

Registry

ClinicalTrials.gov

Start date

1 July 2020

Est. completion

31 December 2030

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

To provide data on profile, management, outcome, and evolution over time of CS patients admitted to ICCU; Re-hospitalization

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov